Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
02/2003
02/26/2003CN1398627A Chinese herbal medicine tumor-eliminating drop and its recipe
02/26/2003CN1398620A Capsule made of hairyvein agrimonia herb, the dried rhizome of rehmannia and Chinese angelica
02/26/2003CN1398600A Yang-strengthening chlorophyta tortoise capsule and its prepn
02/26/2003CN1398595A Medicine for treating women's inflammation
02/26/2003CN1398590A Recipe and prepn of progesterone capsule
02/26/2003CA2419744A1 A novel crystal of n-hydroxy-2(s)-methyl-5-ethoxymethoxy-4(s)-¬n-(4-phenoxyphenylcarbonyl)amino|pentanamide and a method for the preparation thereof and a pharmaceutical agent comprising the same as active ingredient
02/25/2003US6525206 Compounds with high monoamine transporter affinity
02/25/2003US6525196 5HT1 antagonists for antidepressant therapy
02/25/2003US6525075 Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta[a]naphthalene
02/25/2003US6525048 Aminomethylphenoxymethyl/benzisoxazole substituted azabicyclic compounds; depression, generalized anxiety disorder, obesity, migraine; 2-(5-Fluoro-benzo(d)isoxazol-3-y)-7-(3-morpholin-4-ylmethylphenoxymethyl) -octahydro-pyrido(1,2-a)pyrazine;
02/25/2003US6525047 Which are growth hormone secretogogues and increase the level of endogenous growth hormone; treating osteoporosis, congestive heart failure, frailty associated with aging, obesity; accelerating bone fracture repair
02/22/2003CA2355573A1 Method for the synthesis of peptide salts, their use and the pharmaceutical preparations, containing peptide salts
02/21/2003WO2002016354A1 Chromenone derivatives and their use for treating diseases in conjunction with 5-hta1 receptors and/or dopamine d2 receptors
02/21/2003CA2420206A1 Chromenone derivatives and the use thereof for the treatment of diseases in connection with 5-hta1 receptors and/or dopamine d2 receptors
02/21/2003CA2398766A1 Treatments for female sexual dysfunction and methods for identifying compounds useful for treating female sexual dysfunction
02/20/2003WO2003014731A2 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use
02/20/2003WO2003014322A2 Proteins associated with cell growth, differentiation, and death
02/20/2003WO2003014321A2 Compositions and methods for modulation of darpp-32 phosphorylation
02/20/2003WO2003014296A2 A group of novel anti-cancer compounds with specific structure
02/20/2003WO2003014287A1 Hops extracts, method for the production and use
02/20/2003WO2003014158A1 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use
02/20/2003WO2003014141A1 17alfa, 21-dihydroxypregnene esters as antiandrogenic agents
02/20/2003WO2003014137A1 Adenosine a3 receptor agonists
02/20/2003WO2003014083A1 Spiro compounds
02/20/2003WO2003014079A1 Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
02/20/2003WO2003013574A1 Melanin-concentrating hormone antagonists
02/20/2003WO2003013571A1 Peptidomimetics of biologically active metallopeptides
02/20/2003WO2003013545A1 Novel benzo-fused heterocycles as endothelin antagonisits
02/20/2003WO2003013537A2 Irinotecan for treatment of cancer
02/20/2003WO2003013536A2 Methods for treatment of cancer using irinotecan based on ugt1a1
02/20/2003WO2003013535A2 Use of irinotecan for improved treatment of cancer based on mdr1
02/20/2003WO2003013534A2 Methods for the treatment of cancer with irinotecan based on cyp3a5
02/20/2003WO2003013533A2 Methods for improved treatment of cancer with irinotecan based on mrp1
02/20/2003WO2003013530A2 Salts of substituted 1, 2, 3, 4-tetrahydroquinoline-2-carboxylic acid derivatives as nmda antagonists
02/20/2003WO2003013529A1 Paroxetine glycyrrhizinate
02/20/2003WO2003013528A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists.
02/20/2003WO2003013515A1 Novel alpha adrenergic agents
02/20/2003WO2003013509A1 N-phenylpyrrole guanidine derivatives as melanocortin reception ligands
02/20/2003WO2003013432A2 Methods of use for novel sulfur containing organic nitrate compounds
02/20/2003WO2002102794A3 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
02/20/2003WO2002096927A3 Ribozyme based treatment of female reproductive diseases
02/20/2003WO2002085375A8 Novel hormone composition
02/20/2003WO2002070525A3 Nitrogen-based camptothecin derivatives
02/20/2003WO2002068548A9 Use of erss-selective ligands for regulating fertility and compounds useful therefore
02/20/2003WO2002068387A3 Acylated piperidine derivatives as melanocortin-4 receptor agonists
02/20/2003WO2002065979A3 (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes
02/20/2003WO2002045738A3 Vaccine composition containing transforming growth factor alpha
02/20/2003WO2002032842A9 Compounds with high monoamine transporter affinity
02/20/2003WO2002030882A9 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
02/20/2003WO2002030860A9 Ketone compounds and compositions for cholesterol management and related uses
02/20/2003WO2002026193A9 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
02/20/2003WO2002022621B1 INTERPHENYLENE 7-OXABICYCLIC[2.2.1]HEPTANE OXAZOLES AS PROSTAGLANDIN F2a ANTAGONISTS
02/20/2003US20030036651 As phosphodiesterase inhibitor for prophylaxis and therapy of bronchial asthma; pneumonic diseases, pulmonary emphysema, chronic obstructive pulmonary disease acute respiratory distress syndrome (ARDS), and other respiratory diseases
02/20/2003US20030036566 Administering 4-chloro-1-(p-(2-hydroxyethoxy)phenyl)-1,2-diphenyl-1-butene or a geometric isomer, a stereoisomer, a salt, an ester thereof or a metabolite thereof
02/20/2003US20030036543 Especially as inhibitors of Aurora-2 and GSK-3, for treating diseases such as cancer, diabetes and Alzheimer's disease.
02/20/2003US20030036536 Substituted benzylthioacetic acids and esters
02/20/2003US20030036512 A neurotrophic factor, such as brain-derived neurotrophic factor; treating leptin resistance caused hypertension, sterility, obesity, glucose metabolic abnormality, ischemic disease and growth hormone insufficiency
02/20/2003US20030036185 Novel amino acid sequences for human kidney cadherin-like polypeptides
02/20/2003CA2462200A1 Peptidomimetics of biologically active metallopeptides
02/20/2003CA2457433A1 Novel alpha adrenergic agents
02/20/2003CA2456964A1 Melanin-concentrating hormone antagonists
02/20/2003CA2456942A1 Compositions and methods for modulation of darpp-32 phosphorylation
02/20/2003CA2456881A1 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use
02/20/2003CA2456744A1 Adenosine a3 receptor agonists
02/20/2003CA2456599A1 Spiro compounds
02/20/2003CA2456369A1 Proteins associated with cell growth, differentiation, and death
02/20/2003CA2456144A1 A group of novel anti-cancer compounds with specific structure
02/20/2003CA2456103A1 Salts of substituted 1, 2, 3, 4-tetrahydroquinoline-2-carboxylic acid derivatives
02/20/2003CA2455871A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists.
02/20/2003CA2454648A1 Irinotecan for treatment of cancer
02/20/2003CA2454643A1 Methods for the treatment of cancer with irinotecan based on cyp3a5
02/20/2003CA2454640A1 Methods for treatment of cancer using irinotecan based on ugt1a1
02/20/2003CA2454637A1 Use of irinotecan for improved treatment of cancer based on mdr1
02/20/2003CA2454627A1 Methods for improved treatment of cancer with irinotecan based on mrp1
02/20/2003CA2454417A1 Novel benzo-fused heterocycles as endothelin antagonists
02/20/2003CA2453433A1 Methods of use for novel sulfur containing organic nitrate compounds
02/19/2003EP1284273A2 Estra-1,3,5(10)-trien-3-sulfamates a process for their production and pharmaceutical compositions containing them
02/19/2003EP1284272A1 Estra-1,3,5(10)-triene derivatives
02/19/2003EP1283887A1 Chimeric arterivirus-like particles
02/19/2003EP1283886A2 Intracellular signaling proteins
02/19/2003EP1283823A1 Novel mmp-2/mmp-9 inhibitors
02/19/2003EP1283723A2 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
02/19/2003EP1283707A1 Polymerizable compositions and methods of use
02/19/2003EP1119571B1 Tricyclic delta3-piperidines as alpha2-antagonists
02/19/2003EP1039888B1 Method of increasing the production and improving the quality of semen
02/19/2003EP1001788B1 Boron carbohydrate complexes and uses thereof
02/19/2003CN1398189A Combination therapy of radiation and COX-2 inhibitor for treatment of neoplasia
02/19/2003CN1398186A Pharmaceutical compsn. comprising pectin effective in inhibiting male productive toxxicity
02/19/2003CN1397323A Chinese medicine for treating endometriosis and its preparing process
02/19/2003CN1397316A Prescription and preparing process for haemostatic 'Gonghuan' tablet
02/19/2003CN1397286A Prescription and preparing process of medicine 'Rukang' for treating mastitis
02/19/2003CN1397271A Process for preparing medicine applying system in cavity or duct
02/19/2003CN1101701C composn. for nasal administration of desmopressin, its prepn. process and use
02/19/2003CN1101693C Externally applied Chinese medicine
02/19/2003CN1101690C Chinese herbal medicine for treating mastopathy
02/18/2003US6521746 Leukotoxin polypeptide fused to gonadotropin releasing hormone/factor multimer; increased immunogenicity
02/18/2003US6521657 Indole derivatives which are agonists of the progesterone receptor and useful for treatment of carcinoma and adenocarcinomas of uterine leiomyomata, endometriosis or polycystic ovary syndorme in a mammal
02/18/2003US6521641 Retinoic acid receptor antagonists or inverse agonists; reversibly inhibiting or preventing spermatogenesis
02/18/2003US6521620 Suppressing tumors, especially breast cancers; antiproli-ferative agents; arthritis, vascular restenosis, psoriasis and angiogenesis; extremely low cytotoxicity
02/18/2003CA2420042A1 Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient
1 ... 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 ... 557